Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2010-03-11
2011-12-27
Wilson, James O (Department: 1624)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C544S322000, C544S336000, C546S133000, C548S247000, C549S074000
Reexamination Certificate
active
08084463
ABSTRACT:
Compounds of Formula (I); in salt or zwitterionic form wherein R1, R2, R3and R4have the meanings as indicated in the specification, are useful for treating conditions that are mediated by the muscarinic M3 receptor, especially inflammatory or obstructive airways diseases. Pharmaceutical compositions that contain the compounds and a process for preparing the compounds are also described.
REFERENCES:
patent: 3714357 (1973-01-01), Gueremy et al.
patent: 1703/1997 (1998-04-01), None
patent: 1889/2000 (2001-05-01), None
patent: 2031/2001 (2002-07-01), None
patent: 3158/2001 (2002-10-01), None
patent: 3193/2001 (2002-11-01), None
patent: 1246/2003 (2004-04-01), None
patent: 918/2004 (2005-02-01), None
patent: 528/2005 (2006-02-01), None
patent: 963/2005 (2006-04-01), None
patent: 1862/2005 (2006-07-01), None
patent: 1300407 (2003-04-01), None
patent: 2012964 (1970-03-01), None
patent: WO98/07722 (1998-02-01), None
patent: 01/04118 (2001-01-01), None
patent: WO02/15662 (2002-02-01), None
patent: WO02/16355 (2002-02-01), None
patent: WO02/16356 (2002-02-01), None
patent: WO02/16357 (2002-02-01), None
patent: WO02/16358 (2002-02-01), None
patent: WO02/17358 (2002-02-01), None
patent: WO02/535654 (2002-07-01), None
patent: WO2002/051841 (2002-07-01), None
patent: 03/053966 (2003-07-01), None
patent: WO2004/000840 (2003-12-01), None
patent: 2004/096800 (2004-11-01), None
patent: 2005/090342 (2005-09-01), None
patent: WO2005/104745 (2005-11-01), None
patent: WO2006/010452 (2006-02-01), None
Jordon, V.C. Nature Reviews: Drug Discovery, 2, 2003, 205.
Berge, et al., J. Pharm. Sci., 66, (1), 1977, 1-19.
Serajuddin, A.T.M. Advanced Drug Delivery Reviews, 59, 2007, 603-616.
Dorwald, F. Zaragoza. Side Reactions in Organic Synthesis: A Guide to Successful Synthesis Design, Weinheim: WILEY-VCH Verlag GmbH & Co. KGaA, 2005, Preface.
Kumar, et al. Drug Discovery Today, 12, 23/24, 2007, 1048-1053.
Baettig Urs
Collingwood Stephen P
Cox Brian
Garad Sudhakar D
Kim Hyungchul
McAvoy Cozette M
Novartis AG
Willis Douglas M
Wilson James O
LandOfFree
Quinuclidine derivatives and their use as muscarinic M3... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Quinuclidine derivatives and their use as muscarinic M3..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Quinuclidine derivatives and their use as muscarinic M3... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4314483